Related Experiment Video
Updated: Jun 18, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Drugs controlling proteinuria of patients with Alport syndrome
Jian-Guo Li1, Jie Ding, Fang Wang
1Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Background:
Proteinuria is one of the risk factors for the progression of renal diseases including Alport syndrome (AS), a hereditary glomerular renal disease. This study aimed to evaluate the efficacy of angiotensin converting enzyme inhibitors (ACEIs) and/or tripterygium, a Chinese herbal medicine widely used in Chinese patients with hematuria and proteinuria, on proteinuria in patients with AS.
Methods:
Twenty-nine children were enrolled into this retrospective study. Patients were divided into 3 therapy groups: ACEI group, tripterygium group, and ACEI plus tripterygium group.
Results:
In the 29 children, 23 were male and 6 female. In the ACEI group and the tripterygium group, the effective rate was 87.5% and 25.0%, respectively and in the ACEI plus tripterygium group was 42.9%.
Conclusions:
ACEI is effective in controlling proteinuria of AS patients. Tripterygium should be carefully administered in controlling proteinuria of AS patients.
More Related Videos
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drug Elimination by Renal Route: Tubular Secretion
Drug Distribution: Plasma Protein Binding
Renal Drug Excretion: Tubular Secretion

